Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes
Centre for Precision Health / School of Medical and Health Sciences
National Natural Science Foundation of China (Numbers: 81872708 and 82073668 to LX. Tao)
Background: Arterial stiffness, glycemic control and blood pressure are risk factors of macrovascular complications in type 2 diabetes. This study aimed to investigate the combined association of arterial stiffness, glycemic control and hypertension status with the occurrence of diabetic macrovascular complication. Methods: A total of 1870 patients of diabetes were enrolled from Beijing Health Management Cohort between 2008 and 2018 as baseline, and then followed for macrovascular complication onset. We proposed a composite risk score (0 – 4) by arterial stiffness severity, pool glycemic control and hypertension status. Cox model was used to estimate the hazard ratio (HR) and 95 % confidence interval (CI). Results: The mean age (SD) of this population was 59.90 (12.29) years. During a median follow-up of 4.0 years, 359 (19.2 %) patients developed macrovascular complication. Compared to the normal arterial stiffness and good glycemic control group, patients with severe arterial stiffness and pool glycemic control had the highest risk of macrovascular complications (HR: 2.73; 95 % CI: 1.42 – 5.25). Similarly, those of severe arterial stiffness and hypertension had the highest risk (HR: 2.69; 95 % CI: 1.61 – 4.50). Patients of the composite score > 2 had a significantly increased risk of macrovascular complication. Conclusion: This study suggested the clinical importance of combined evaluation of arterial stiffness, glycemic control and hypertension status for the risk stratification and management of macrovascular complication of type 2 diabetes.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Wu, Z., Yu, S., Zhang, H., Guo, Z., Zheng, Y., Xu, Z., ... & Guo, X. (2022). Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes. Cardiovascular Diabetology, 21, 262. https://doi.org/10.1186/s12933-022-01696-1